Investment and Business Development for Future Growth
First written in FY2016. 6 of 9 entries say "Advanced", first in FY2021-Q1. Latest entry: 2026-05-21.
The whole theme swung hardest in 2025: 2 of 15 companies on the "Worse" side.
13 other companies' latest entry also says "Advanced".
- 2026-05-21AdvancedGeneral Meetings of Shareholders
「In December 2025, we began selling the new “Term Cancer Insurance” and the renewed “Whole Life Cancer Insurance,” and the term product series targeting younger customers became a driver of individual insurance performance.」
Product development included the launch of Term Cancer Insurance and the renewal of Whole Life Cancer Insurance. - FY2026-H1AdvancedAnnual report
「The company also invests in shares as investment assets held for purposes other than pure investment, with the aim of enhancing the corporate value or performance of the group, and may continue to do so in the future. Although the company conducts thorough reviews when selecting investees and making investment decisions, deterioration in market conditions or an investee's financial condition or performance, or foreign-exchange fluctuations, could adversely affect the group's financial condition and performance. During the interim consolidated accounting period, the company made a new investment of ¥3,000 million in Advance Create Co.,Ltd. in connection with a capital and business alliance with that company.」
The company made a new investment of ¥3,000 million in connection with its capital and business alliance with Advance Create, for the purpose of enhancing corporate value and performance. - FY2024AdvancedAnnual report
「In addition, together with Eisai Co.,Ltd., with which it entered into a capital and business alliance in fiscal 2022, the company developed dementia insurance "be" with the aim of helping reduce the medical and nursing-care burden on people in Japan's aging society, and has been selling it since April 2024.」
Product development in the dementia field progressed from the development stage to the launch of sales of dementia insurance "be." - FY2024-Q1AdvancedAnnual report
「Regarding products, the company is advancing product development in the dementia field.」
For future product development, the company identified dementia as a specific development focus. - FY2022AdvancedAnnual report
「During the fiscal year, the company conducted an overseas offering of new shares in September 2021, aiming to accelerate "Growth" and "Transformation."」
To accelerate growth and business transformation, the company raised capital through an overseas offering in September 2021 and specified a policy of using the funds for marketing, system development and investment in new businesses. - FY2021-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 3 July 2020, the company resolved to issue new shares through an overseas offering and conduct a secondary offering, and payment was completed on 20 July 2020. Use of proceeds: The funds are primarily planned to be allocated to (1) operating expenses, mainly marketing expenses associated with acquiring new business, (2) system development expenses to address rapid changes in the business environment, and (3) investment to create new businesses.」
The company completed fundraising through an overseas offering and specified plans to allocate the funds to acquiring new business, system development and investment in creating new businesses. - FY2018RestatedAnnual report
「We will also advance research and development, including the development of new products and new ways of delivering insurance, such as analyzing health and medical data and exploring the use of technologies well suited to life insurance sales.」
The company continues to indicate the direction of future investment and research and development, including health and medical data analysis, new products and new ways of delivering insurance. - FY2017RestatedAnnual report
「Efforts to invest in the future and conduct research and development」
The company has reiterated its policy of continuing investment in the future and research and development as part of its business strategy under the medium-term plan. - FY2016First statedAnnual report
「We will seek to continuously deploy a certain level of management resources in planned investment and business development to achieve future growth.」
The company has indicated a policy of undertaking planned investment and business development for future growth, in addition to investing in its existing businesses.